Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Obstructive Lung Diseases

Free Subscription Articles published in Chest Retrieve available abstracts of 210 articles: HTML format

Single Articles

October 2026
1. YANG F, Marshall DC, Howell I, Hinks TSC, et al
   Exacerbation trajectories in biologic-eligible severe asthma patients.
   Chest. 2026 Oct 5:S0012-3692(26)06789-9. doi: 10.1016/j.chest.2026.
   PubMed     Abstract available
   
   
   
2. NAIR P, Zhang K, Lauks S, Kjarsgaard M, et al
   Sputum cellularity and health services utilization among patients with asthma and COPD.
   Chest. 2026 Oct 3:S0012-3692(26)06782-6. doi: 10.1016/j.chest.2026.
   PubMed     Abstract available
   
   
   
3. 
   Corrigendum to: Rivard R, Mailhot-Larouche A, Borg C, et al. Hypereosinophilia With Pseudomonas aeruginosa Infection in Patients With Asthma on Anti-Inteleukin-5 Biologics. CHEST. 2026;170(1):E1-E4.
   Chest. 2026;170:1346.
   PubMed    
   
   
   
4. KIM H, Chang Y, Yoon S, Ryu S, et al
   Chest Radiograph-Derived Age Acceleration as an Early Marker of Pulmonary Dysfunction in Middle-Aged Asian Adults.
   Chest. 2026;170:1174-1186.
   PubMed     Abstract available
   
   
   
5. BOURDIN A, Beclin MF, Chanez P, Vachier I, et al
   Predicting Clinical Response to Benralizumab Using CT Imaging: Prognostic CT Air-Trapping for the Early Identification of Benralizumab Responders Among Eosinophilic Asthma Patients (BenraliScan) Study.
   Chest. 2026;170:1024-1036.
   PubMed     Abstract available
   
   
   
6. PU J, Hong S, He JQ
   Associations of Mucus Plug With Prognosis in COPD: A Systematic Review and Meta-Analysis.
   Chest. 2026;170:1074-1084.
   PubMed     Abstract available
   
   
   September 2026
7. MACRAE S, Swenson C, Flowers RC, Hurtado RM, et al
   Delivering Bronchiectasis and NTM Care in Safety-Net Health Systems: A Practical Framework for Implementation.
   Chest. 2026 Sep 19:S0012-3692(26)06669-9. doi: 10.1016/j.chest.2026.
   PubMed     Abstract available
   
   
   
8. JUNG F, MacRae S
   Non-Cystic Fibrosis Bronchiectasis in the United States: Prevalence Trends in a Large Electronic Health Record Population, 2015-2025.
   Chest. 2026 Sep 19:S0012-3692(26)06671-7. doi: 10.1016/j.chest.2026.
   PubMed     Abstract available
   
   
   
9. LI Y, Wang Y, Zhang M, Wang G, et al
   Mixed Mucus Plug-Emphysema Subtype and Acute Exacerbation in Chronic Obstructive Pulmonary Disease.
   Chest. 2026 Sep 19:S0012-3692(26)06663-8. doi: 10.1016/j.chest.2026.
   PubMed     Abstract available
   
   
   
10. CANONICA GW, Christoff GC, Tsai MJ, Tran TN, et al
    Assessing the impact of earlier initiation of biologics on clinical remission and other outcomes in a global real-life severe asthma cohort from CHRONICLE, ISAR and OPCRD.
    Chest. 2026 Sep 9:S0012-3692(26)06552-9. doi: 10.1016/j.chest.2026.
    PubMed     Abstract available
    
    
    
11. STOLLER JK
    Liver Transplantation Prevents Emphysema Progression in Alpha-1.
    Chest. 2026;170:e105-e106.
    PubMed    
    
    
    
12. CAZZOLA M, Matera MG
    Biologics for Asthma and COPD Exacerbations: Conceptual Rationale and Clinical Uncertainty.
    Chest. 2026;170:669-671.
    PubMed    
    
    
    
13. WU F, Wan Q, Tian H, Zheng Y, et al
    Prognostic Significance of Mild Exacerbations or 1 Moderate Exacerbation in COPD: A Prospective Community-Based Cohort Study.
    Chest. 2026;170:725-738.
    PubMed     Abstract available
    
    
    August 2026
14. RICHARDSON H, Pollock J, Chan R, Chalmers JD, et al
    The airway microbiome in asthma.
    Chest. 2026 Aug 31:S0012-3692(26)06527-X. doi: 10.1016/j.chest.2026.
    PubMed     Abstract available
    
    
    
15. NAM Y, Cho HR, Kim E, Ko NG, et al
    Incidental Emphysema on Health Screening Chest CT and All-Cause Mortality in a Korean Cohort.
    Chest. 2026 Aug 19:S0012-3692(26)06435-4. doi: 10.1016/j.chest.2026.
    PubMed     Abstract available
    
    
    
16. CHAN ED
    Comparison of Antiinflammatory Therapies for Bronchiectasis.
    Chest. 2026;170:e59-e60.
    PubMed    
    
    
    
17. ELDEIRY D, Geyer A, Machnicki S
    A Case of Progressively Worsening Dyspnea and Chronic Cough in a Patient With Known Bronchiectasis.
    Chest. 2026;170:e35-e38.
    PubMed     Abstract available
    
    
    
18. CHANDRA D
    Not All Emphysema Is Equal: Centrilobular Subtype as a Window Into Cardiovascular Risk.
    Chest. 2026;170:287-289.
    PubMed    
    
    
    July 2026
19. LIU ZB, Cao J, Qu QR, Wang L, et al
    Impact of Bronchiectasis on Treatment Outcomes in Patients With Nontuberculous Mycobacterial Pulmonary Disease: A 10-Year Retrospective Cohort Study Stratified by Bronchiectasis Severity.
    Chest. 2026 Jul 28:S0012-3692(26)06314-2. doi: 10.1016/j.chest.2026.07.5217.
    PubMed     Abstract available
    
    
    
20. KANG D, Chang Y, Oh YJ, Hwang JH, et al
    Low levels of emphysema burden on LDCT and spirometry-based OLD: Joint Effects on Mortality.
    Chest. 2026 Jul 28:S0012-3692(26)06311-7. doi: 10.1016/j.chest.2026.07.5214.
    PubMed     Abstract available
    
    
    
21. LIAO KM, Huang SC, Kuo CY, Hsu WH, et al
    Risk of Lymphoma in Patients with Asthma Treated with Dupilumab Compared with Other Biologic Agents: A Retrospective Cohort Study.
    Chest. 2026 Jul 28:S0012-3692(26)06308-7. doi: 10.1016/j.chest.2026.07.5213.
    PubMed     Abstract available
    
    
    
22. SINGER D, Steffens A, La EM, Buikema AR, et al
    Effectiveness of the adjuvanted RSVPreF3 vaccine in preventing major adverse cardiovascular events and severe exacerbations of chronic obstructive pulmonary disease and asthma among US adults aged >/=60 years.
    Chest. 2026 Jul 23:S0012-3692(26)06182-9. doi: 10.1016/j.chest.2026.
    PubMed     Abstract available
    
    
    
23. THOMSON R, Thornton C, Aksamit T, Barker A, et al
    Management of Adult Bronchiectasis: An American College of Chest Physicians Clinical Practice Guideline.
    Chest. 2026 Jul 21:S0012-3692(26)06180-5. doi: 10.1016/j.chest.2026.
    PubMed     Abstract available
    
    
    
24. ZHA BS, Young V, Kathpalia P, Varghese C, et al
    Aspiration and GERD in Bronchiectasis: Bridging Pulmonology, Gastroenterology, and Otolaryngology in an At-Risk Population.
    Chest. 2026 Jul 9:S0012-3692(26)00957-8. doi: 10.1016/j.chest.2026.
    PubMed     Abstract available
    
    
    
25. KHOR YH, Marinescu DC, Manganas H, Morisset J, et al
    Prevalence, detection, and trajectory of combined pulmonary fibrosis and emphysema.
    Chest. 2026 Jul 7:S0012-3692(26)00952-9. doi: 10.1016/j.chest.2026.
    PubMed     Abstract available
    
    
    
26. RIVARD R, Mailhot-Larouche S, Borg C, Pujan P, et al
    Hypereosinophilia With Pseudomonas aeruginosa Infection in Patients With Asthma on Anti-Inteleurkin-5 Biologics.
    Chest. 2026;170:e1-e4.
    PubMed     Abstract available
    
    
    
27. TASHKIN DP
    Does Inhaled Marijuana Use Have an Adverse Effect On Asthma?: An Incomplete Answer.
    Chest. 2026;170:3-5.
    PubMed    
    
    
    
28. ZHOU Y, Chen C, Wang Z, Wu F, et al
    Efficacy and Safety of Ensifentrine in Chinese Participants With COPD: The ENHANCE-CHINA Randomized Clinical Trial.
    Chest. 2026;170:88-100.
    PubMed     Abstract available
    
    
    
29. EGGLESTON RH, Alkhateeb H, Pennington KM, Zhang Z, et al
    Can Posttransplant Cyclophosphamide Reduce Bronchiolitis Obliterans Syndrome Risk Through Chronic Graft vs Host Disease Prevention?: A Multicenter Cohort Study.
    Chest. 2026;170:169-180.
    PubMed     Abstract available
    
    
    
30. KUMAR G, Vidal M, Alaws H, Patel D, et al
    The Epidemiology of Cryptogenic Organizing Pneumonia: An Analysis of Data From the Nationwide Inpatient Sample.
    Chest. 2026;170:149-156.
    PubMed     Abstract available
    
    
    
31. RAMAKRISHNAN S, Petousi N, Bon J, Pavord ID, et al
    Win Ratio Analysis to Clarify Clinical Benefits: A Post Hoc Analysis of Phase 3 BOREAS and NOTUS (Two Pivotal Studies to Assess the Efficacy, Safety, and Tolerability of Dupilumab in Patients With Moderate-to-Severe COPD With Type 2 Inflammation).
    Chest. 2026;170:76-87.
    PubMed     Abstract available
    
    
    June 2026
32. DOUMAT G, Haroon S, Maalouf NM, Jain R, et al
    Bone Disease in Non-Cystic Fibrosis Bronchiectasis: Connections, Mechanisms, and Care Gaps.
    Chest. 2026 Jun 3:S0012-3692(26)00769-5. doi: 10.1016/j.chest.2026.
    PubMed     Abstract available
    
    
    
33. WANG Y, Tian G
    Reproducibility and Clinical Interpretation of "Low-Risk" Intermittent Pediatric Asthma in Claims Data.
    Chest. 2026;169:e199-e200.
    PubMed    
    
    
    
34. 
    Corrigendum to: Sheikh S, Eisner M, Wheaton K, et al. Intermittent Asthma and Risk of Severe Exacerbation in Children. CHEST. 2026;169(1):41-51.
    Chest. 2026;169:1775-1776.
    PubMed    
    
    
    
35. LYON ZM, Kolaitis NA
    Is It Time to Focus Efforts to Better Understand Group 3 Pulmonary Hypertension in Patients With Cystic Fibrosis and Non-Cystic Fibrosis Bronchiectasis?
    Chest. 2026;169:1432-1433.
    PubMed    
    
    
    
36. JIA S
    Antiinflammatory Therapy in Bronchiectasis: Successes, Failures, and a Call for a More Precise Approach.
    Chest. 2026;169:1427-1429.
    PubMed    
    
    
    
37. COLLINS SE, Kirby M, Smith BM, Rampuri ZH, et al
    A Randomized, Placebo-Controlled, Double-Blind, Crossover Trial of Inhaled Nitric Oxide in Patients With Mild-to-Severe COPD.
    Chest. 2026;169:1524-1535.
    PubMed     Abstract available
    
    
    
38. HE LX, Yang L, Xiao ZK, Qiu R, et al
    Effects of a Novel Dual Phosphodiesterase 3 and 4 Inhibitor TQC3721 in Patients With COPD in China (PACER-II): A Phase 2, Multicenter, Randomized, Double-Anonymized, Placebo-Controlled Trial.
    Chest. 2026;169:1536-1550.
    PubMed     Abstract available
    
    
    May 2026
39. REVEL MP, Goo JM, Vliegenthart R, Silva M, et al
    Smoking-Related Comorbidities Detected Through Low-dose CT Lung Cancer Screening: Current Evidence and Future Directions.
    Chest. 2026 May 29:S0012-3692(26)00761-0. doi: 10.1016/j.chest.2026.
    PubMed     Abstract available
    
    
    
40. GARCIA AR, Vollmer I, Blanco I, San Jose Estepar R, et al
    Characterization of CT-Derived Pulmonary Vascular Abnormalities Associated with Pulmonary Hypertension in Chronic Lung Disease.
    Chest. 2026 May 27:S0012-3692(26)00704-X. doi: 10.1016/j.chest.2026.
    PubMed     Abstract available
    
    
    
41. JOE A, Rosser FJ, Gaietto K, Yue M, et al
    Dietary patterns and asthma endotypes in Puerto Rican youth.
    Chest. 2026 May 19:S0012-3692(26)00645-8. doi: 10.1016/j.chest.2026.
    PubMed     Abstract available
    
    
    
42. GRAMEGNA A, Maruca G, Caminati M, Imeri G, et al
    Use of an anti-TSLP agent in patients with asthma and clinically significant bronchiectasis: a case series.
    Chest. 2026 May 14:S0012-3692(26)00635-5. doi: 10.1016/j.chest.2026.
    PubMed    
    
    
    
43. ALISMAIL A, Ireland K
    Accuracy and Clinical Reasoning in Asthma Care: Insights from 14 Large Language Models.
    Chest. 2026;169:1167-1168.
    PubMed    
    
    
    
44. SONG JH, Kim Y
    When Routine Becomes Risk: Proton Pump Inhibitors in COPD and Asthma.
    Chest. 2026;169:1157-1158.
    PubMed    
    
    
    
45. DEHONDT V, Van Vaerenbergh F, Verhamme K, Lahousse L, et al
    Exacerbation Risk by Chronic Proton Pump Inhibitor Use in Obstructive Lung Diseases.
    Chest. 2026;169:1218-1227.
    PubMed     Abstract available
    
    
    April 2026
46. WECHSLER ME, Quart B, Collazo R
    Eosinophil Counts in Adults with Asthma Treated with Anti-IL-4Ralpha Rademikibart: Exploratory Analyses in a Randomized Trial.
    Chest. 2026 Apr 28:S0012-3692(26)00563-5. doi: 10.1016/j.chest.2026.
    PubMed     Abstract available
    
    
    
47. SANDHU E, Ragunayakam N, Mappanasingam AA, Friedlander Y, et al
    Dupilumab Reduces Mucus Radiodensity and New Plug Formation in Asthma.
    Chest. 2026 Apr 21:S0012-3692(26)00465-4. doi: 10.1016/j.chest.2026.
    PubMed     Abstract available
    
    
    
48. GATT D, Ben-Shitrit I, Golan-Tripto I, Goldbart A, et al
    Meconium Aspiration Syndrome and the Association with Preschool Asthma.
    Chest. 2026 Apr 21:S0012-3692(26)00457-5. doi: 10.1016/j.chest.2026.
    PubMed     Abstract available
    
    
    
49. GRAVES JM, Krings JG
    Payer-Driven Inhaler Switching: An Underrecognized Threat to Asthma and COPD Care.
    Chest. 2026;169:867-869.
    PubMed    
    
    
    
50. LOSIER A
    Fungal Sensitization and Bronchiectasis: Time for an Endotype-Based Approach?
    Chest. 2026;169:859-861.
    PubMed    
    
    
    
51. PEIRCE AM, Hogan CK, Weinstein JB, Seelye SM, et al
    Clinician Views on Inhaler Substitution in the Veterans Health Administration.
    Chest. 2026;169:1039-1050.
    PubMed     Abstract available
    
    
    
52. SON E, Seo H, Ra SW, Park SJ, et al
    Clinical Outcomes in Patients With COPD With Disease Stability: Data from the Korea COPD Subgroup Study Cohort.
    Chest. 2026;169:958-967.
    PubMed     Abstract available
    
    
    
53. LIN CY, Zhong BK, Chou YT, Kuo CW, et al
    Eosinophilic Versus Non-Eosinophilic Acute Exacerbations of COPD and Subsequent Cardiovascular Event.
    Chest. 2026 Apr 1:S0012-3692(26)00432-0. doi: 10.1016/j.chest.2026.
    PubMed     Abstract available
    
    
    March 2026
54. GONZALEZ J, Yip R, Zhang J, Jirapatnakul A, et al
    Linking lungs and heart: centrilobular emphysema progression predicts coronary artery calcification progression during 18 years of follow-up.
    Chest. 2026 Mar 31:S0012-3692(26)00431-9. doi: 10.1016/j.chest.2026.
    PubMed     Abstract available
    
    
    
55. KRISTIANSSON L, Seiler C, Braman Eriksson A, Sundh J, et al
    Suggested novel risk factors for Swimming-Induced Pulmonary Edema - asthma and limited open water swimming experience.
    Chest. 2026 Mar 26:S0012-3692(26)00409-5. doi: 10.1016/j.chest.2026.
    PubMed     Abstract available
    
    
    
56. DEPTA F, Sedlak V, Koblizek V, Bodnarova S, et al
    Pulmonary Dynamics of the Bronchodilator Response in Volume-Responsive Asthma and COPD.
    Chest. 2026 Mar 26:S0012-3692(26)00418-6. doi: 10.1016/j.chest.2026.
    PubMed    
    
    
    
57. TANU F, Mortensen EM, Sacco SJ, Demirci D, et al
    Association of Inhaling Marijuana with Asthma Attacks: An Analysis of Nationally Representative Survey Data.
    Chest. 2026 Mar 16:S0012-3692(26)00324-7. doi: 10.1016/j.chest.2026.
    PubMed     Abstract available
    
    
    
58. RICHARDS C, Brunton AE, Choate R, Winthrop K, et al
    CFTR Mutations and Potential Associations with Increased Rates of Pulmonary Infections Among Patients from the US Bronchiectasis and NTM Research Registry.
    Chest. 2026 Mar 14:S0012-3692(26)00303-X. doi: 10.1016/j.chest.2026.
    PubMed    
    
    
    
59. TOUMPANAKIS D, Kim Y, Usmani OS
    Small Airways Disease in Patients With COPD: A Question-and-Answer Approach for Everyday Clinical Practice.
    Chest. 2026;169:641-651.
    PubMed     Abstract available
    
    
    February 2026
60. GUNASEGAREN MD, Lee CH
    Differentiating Acute Pulmonary Edema and Asthma With the Lung Curtain Swing vs Time Graph: A Novel Application of Anatomical M-Mode Evaluation of Lung Swing.
    Chest. 2026;169:e61-e66.
    PubMed    
    
    
    
61. WU F, Huang S, Zhou K, Xia T, et al
    Clinical Validation of a Multidimensional Diagnostic Approach for COPD in Chinese Individuals.
    Chest. 2026;169:371-384.
    PubMed     Abstract available
    
    
    
62. EKSTROM M, Li PZ, Bourbeau J, Tan WC, et al
    When to Best Assess Breathlessness Abnormality During Incremental Cardiopulmonary Cycle Exercise Testing.
    Chest. 2026;169:449-461.
    PubMed     Abstract available
    
    
    January 2026
63. RIEMANN S, Meulmeester FL, Mailhot-Larouche S, Ramakrishnan S, et al
    Sex does not modify prediction of asthma attacks by clinical risk factors and Type-2 biomarkers.
    Chest. 2026 Jan 30:S0012-3692(26)00131-5. doi: 10.1016/j.chest.2025.
    PubMed     Abstract available
    
    
    
64. CHANDEL A, Turkington S, King CS, Singhal A, et al
    Pulmonary hypertension prevalence and significance in lung transplant recipients with cystic fibrosis and non-cystic fibrosis bronchiectasis.
    Chest. 2026 Jan 27:S0012-3692(26)00127-3. doi: 10.1016/j.chest.2025.
    PubMed     Abstract available
    
    
    
65. YADAV CP, Lim LHM, Price D, Roy R, et al
    Interactive Pathways of Key Prognostic Factors in Severe Asthma: A Bayesian Network Comparison of Clinical Trials & Real-World Data.
    Chest. 2026 Jan 24:S0012-3692(26)00125-X. doi: 10.1016/j.chest.2026.
    PubMed     Abstract available
    
    
    
66. YAMAMOTO S, Niitsu T, Fukushima K, Shiozawa A, et al
    Efficacy of Anti-Inflammatory Therapies for Adults with Non-Cystic Fibrosis Bronchiectasis: A Systematic Review and Network Meta-Analysis.
    Chest. 2026 Jan 12:S0012-3692(26)00010-3. doi: 10.1016/j.chest.2025.
    PubMed     Abstract available
    
    
    
67. ZHA BS, Ieong M, Cheng I, Bokser S, et al
    Formation and Growth of a Bronchiectasis and Pulmonary NTM Multidisciplinary Program Using a Patient-Centered and Integrated Care Model Improves Outcomes.
    Chest. 2026 Jan 12:S0012-3692(25)05831-3. doi: 10.1016/j.chest.2025.
    PubMed     Abstract available
    
    
    
68. SWAMI N, Hong JH, Kho S, Kang HM, et al
    Associations between Prior Lung Diseases and Risk of Lung Cancer in Populations With No Smoking History: A Systematic Review and Meta-Analysis.
    Chest. 2026 Jan 12:S0012-3692(26)00004-8. doi: 10.1016/j.chest.2025.
    PubMed     Abstract available
    
    
    
69. METERSKY ML, Hunt CR, Addrizzo-Harris DJ, Aksamit TR, et al
    The Bronchiectasis and Non-Tuberculous Mycobacterial Care Center Network: Improving Access and Quality of Care.
    Chest. 2026;169:34-36.
    PubMed    
    
    
    
70. SUISSA S, Ernst P
    Short-Acting Beta-Agonists or No Short-Acting Beta-Agonists for Mild Asthma.
    Chest. 2026;169:1-2.
    PubMed    
    
    
    
71. DUGGAL K, Wu F, Parvez F, Ahmed A, et al
    Association Between Betel Quid Consumption and Respiratory Disease Mortality in a Prospective Bangladeshi Cohort.
    Chest. 2026;169:84-93.
    PubMed     Abstract available
    
    
    
72. OZALTIN B, Chapman R, Follet T, Vermant M, et al
    Mortality Outcomes and Angiotensin-Converting Enzyme Inhibitor Use in Patients With Idiopathic Pulmonary Fibrosis.
    Chest. 2026;169:139-147.
    PubMed     Abstract available
    
    
    
73. KRIMSKY WS, Mammarappallil JG, Kim V, Bannan B, et al
    Airway Mucus Plugging in Chronic Bronchitis and the Impact of Bronchial Rheoplasty.
    Chest. 2026;169:73-83.
    PubMed     Abstract available
    
    
    December 2025
74. VYAS DA, Mein SA, Narasimmaraj PR, Tale AP, et al
    Asthma Morbidity and Medicaid Instability: Implications of National Work Requirements.
    Chest. 2025 Dec 30:S0012-3692(25)05953-7. doi: 10.1016/j.chest.2025.
    PubMed    
    
    
    
75. FLUME P, Bullington W, Christon L, Crawford E, et al
    Structure of a Bronchiectasis and NTM Care Center: a Position Statement by the Bronchiectasis & NTM Association.
    Chest. 2025 Dec 18:S0012-3692(25)05928-8. doi: 10.1016/j.chest.2025.
    PubMed     Abstract available
    
    
    
76. TIEW PY, Narayana JK, Jaggi TK, Koh MS, et al
    Aspergillus fumigatus sensitization is associated with high-risk bronchiectasis.
    Chest. 2025 Dec 10:S0012-3692(25)05826-X. doi: 10.1016/j.chest.2025.
    PubMed     Abstract available
    
    
    
77. LI PY, Gershon A, Kouri A
    Evaluating the Accuracy of Large Language Models in Answering Asthma Multiple Choice and Objective Structured Clinical Examination Questions.
    Chest. 2025 Dec 8:S0012-3692(25)05816-7. doi: 10.1016/j.chest.2025.
    PubMed     Abstract available
    
    
    
78. TAILLE C, Hamidi F, Heddebaut N, Pote N, et al
    Impact of mepolizumab on airway remodeling and inflammation in severe eosinophilic asthma.
    Chest. 2025 Dec 5:S0012-3692(25)05814-3. doi: 10.1016/j.chest.2025.
    PubMed     Abstract available
    
    
    
79. SOLOMON GM, Dean NC
    Endotypes in Bronchiectasis: Expanding Progress.
    Chest. 2025;168:1275-1276.
    PubMed    
    
    
    
80. CANT E, Bottier M, Shuttleworth M, Stobo J, et al
    Inflammatory and Mucociliary Dysfunction-Based Endotypes Across the Spectrum of Chronic Airway Diseases.
    Chest. 2025;168:1317-1329.
    PubMed     Abstract available
    
    
    
81. WU F, Tang G, Deng Z, Wan Q, et al
    Discriminative Accuracy of Simplified Spirometry for Identifying Spirometry-Defined COPD in the Community.
    Chest. 2025;168:1343-1354.
    PubMed     Abstract available
    
    
    
82. DAI C, Wu F, Tian J, Cui J, et al
    Lung Function Decline and Airflow Limitation Risk in Preserved Ratio Impaired Spirometry Subtypes by Smoking Status.
    Chest. 2025;168:1330-1342.
    PubMed     Abstract available
    
    
    November 2025
83. CELIS-PRECIADO CA, Hamou Kuijpers EB, Ramakrishnan S, Howell I, et al
    Applying precision medicine to the heterogeneity of asthma attacks.
    Chest. 2025 Nov 13:S0012-3692(25)05695-8. doi: 10.1016/j.chest.2025.
    PubMed     Abstract available
    
    
    
84. LACASSE Y, Joseph V, Casaburi R, Maltais F, et al
    Translating the Mechanisms of Hypoxia to Long-Term Oxygen Prescription in COPD: A Proposal.
    Chest. 2025;168:1120-1130.
    PubMed     Abstract available
    
    
    
85. KENDZERSKA T, Talarico R, Povitz M, Blades K, et al
    Association Between a Recalled Positive Airway Pressure Device and Obstructive Lung Disease: A Province-Based Study.
    Chest. 2025;168:1231-1247.
    PubMed     Abstract available
    
    
    
86. AWAN HA, Chaudhary MFA, El-Sokkary AD, Hoffman EA, et al
    Association of Lung Quantitative CT Scan Textures With Systemic Inflammation and Mortality in COPD.
    Chest. 2025;168:1107-1119.
    PubMed     Abstract available
    
    
    October 2025
87. DE-TORRES JP, Casanova C, Zagaceta J, Marin JM, et al
    Cardiovascular Events in COPD: Complementary Role of Cardiac Risk and Coronary Artery Calcium Scores.
    Chest. 2025 Oct 14:S0012-3692(25)05526-6. doi: 10.1016/j.chest.2025.
    PubMed     Abstract available
    
    
    
88. MARMOR M, Brunton AE, Fraulino D, Ruoss SJ, et al
    Research Letter: The Association Between Incident Nontuberculous Mycobacteria Isolation and Antibiotic Exposure in Patients with Bronchiectasis.
    Chest. 2025 Oct 9:S0012-3692(25)05493-5. doi: 10.1016/j.chest.2025.
    PubMed    
    
    
    
89. CHOI JY, Rhee CK, Lee J
    Lung Cancer Risk in Preserved Ratio Impaired Spirometry and Airway Obstruction: A UK Biobank Study.
    Chest. 2025 Oct 8:S0012-3692(25)05501-1. doi: 10.1016/j.chest.2025.
    PubMed     Abstract available
    
    
    
90. LIU C, Xiong H, Han X, Lv Y, et al
    Association of Physical Frailty With Incidence and Life Expectancy of COPD: A Population-Based Cohort Study.
    Chest. 2025;168:890-900.
    PubMed     Abstract available
    
    
    
91. BOERS E, Allen A, Barrett M, Benjafield AV, et al
    Forecasting the Global Economic and Health Burden of COPD From 2025 Through 2050.
    Chest. 2025;168:880-889.
    PubMed     Abstract available
    
    
    September 2025
92. TEELUCKSINGH S, Davis A, Nelson-Piercy C
    Asthma and Pregnancy: A Narrative Review.
    Chest. 2025 Sep 25:S0012-3692(25)05382-6. doi: 10.1016/j.chest.2025.
    PubMed     Abstract available
    
    
    
93. OBERLE AJ, Abbas F, Adrish M, Agache I, et al
    Biologic Management in Severe Asthma for Adults: An American College of Chest Physician Clinical Practice Guideline.
    Chest. 2025 Sep 24:S0012-3692(25)05380-2. doi: 10.1016/j.chest.2025.
    PubMed     Abstract available
    
    
    
94. KL S, Ab C, LA V, St Y, et al
    Pediatric bronchiectasis action management plan to improve clinical outcomes: An RCT.
    Chest. 2025 Sep 8:S0012-3692(25)05164-5. doi: 10.1016/j.chest.2025.
    PubMed     Abstract available
    
    
    
95. NOBLE JH, Warhurst S, Cullen R, Sayers R, et al
    THE DOSE-RESPONSE OF INHALED CORTICOSTEROIDS IN COMBINATION ICS/LABA MAINTENANCE THERAPY FOR ASTHMA: A SYSTEMATIC REVIEW AND META-ANALYSIS.
    Chest. 2025 Sep 3:S0012-3692(25)05145-1. doi: 10.1016/j.chest.2025.
    PubMed     Abstract available
    
    
    
96. KAHRIMAN B, Satici C
    Beyond Emphysema: Unraveling Reversibility and Inflammatory Profiles in Mild to Moderate COPD.
    Chest. 2025;168:e86-e87.
    PubMed    
    
    
    
97. LI Q, Qin KL, Liu Y, Zhang LY, et al
    Recognition Delay and Heterogeneity in Inflammatory Bowel Diseases-Related Bronchiectasis: From Real-World Data to Precision Management.
    Chest. 2025;168:e81-e82.
    PubMed    
    
    
    
98. LI X, Feng S, Yang Y, Liang Z, et al
    Association Between Airway Mucus Plugs and Risk of Moderate-to-Severe Exacerbations in Patients With COPD: Results From a Chinese Prospective Cohort Study.
    Chest. 2025;168:627-638.
    PubMed     Abstract available
    
    
    
99. MUNN JS, Austin PC, Atzema CL, Butler SJ, et al
    Investigating the Long-Term Effects of COVID-19 Infection on Health Care Utilization in Individuals With COPD.
    Chest. 2025;168:613-626.
    PubMed     Abstract available
    
    
    
100. DEHONDT V, Vauterin D, Derom E, Lahousse L, et al
     Association of Timely Spirometry With Lower All-Cause Mortality: A Nationwide Obstructive Cohort Study.
     Chest. 2025;168:602-612.
     PubMed     Abstract available
     
     
     August 2025
101. SHEIKH S, Eisner M, Kelin W, Kilbarger J, et al
     Intermittent Asthma and Risk of Severe Exacerbation in Children.
     Chest. 2025 Aug 27:S0012-3692(25)05124-4. doi: 10.1016/j.chest.2025.07.4089.
     PubMed     Abstract available
     
     
     
102. DAI C, Huang YH
     Bronchiectasis in Patients With Inflammatory Bowel Diseases: Uncertain Association and Future Direction.
     Chest. 2025;168:e45-e46.
     PubMed    
     
     
     
103. COUILLARD S, Ramakrishnan S
     In the Land of Asthma, 4 Risk Factors to Rule Them All.
     Chest. 2025;168:277-279.
     PubMed    
     
     
     
104. MAHLER DA, Halpin DMG
     Selecting an Inhaled Delivery System in COPD.
     Chest. 2025;168:402-409.
     PubMed     Abstract available
     
     
     
105. SCHAEFFER MR, Vanden Bossche L, Beckers K, Verbeke K, et al
     Inhaled Menthol for Dyspnea Relief During Cycle Exercise in COPD: A Randomized Trial.
     Chest. 2025;168:390-401.
     PubMed     Abstract available
     
     
     
106. EKSTROM M, Li PZ, Lewthwaite H, Bourbeau J, et al
     Phenotyping Exertional Breathlessness Using Cardiopulmonary Cycle Exercise Testing in People With Chronic Airflow Limitation.
     Chest. 2025;168:379-389.
     PubMed     Abstract available
     
     
     July 2025
107. BACKMAN H, Myrberg T, Hedman L, Stridsman C, et al
     Importance of Preserved Ratio Impaired Spirometry as a Risk Factor for Development of COPD, Also in Those Who Do Not Smoke.
     Chest. 2025;168:83-94.
     PubMed     Abstract available
     
     
     
108. KALRA S, Hobbs B, Hunninghake GM, Menon AA, et al
     The Association of Interstitial Lung Abnormalities and Preserved Ratio Impaired Spirometry With Mortality.
     Chest. 2025;168:136-145.
     PubMed     Abstract available
     
     
     
109. BHATT SP, Rabe KF, Hanania NA, Vogelmeier CF, et al
     Effect of Dupilumab on Health-Related Quality of Life and Respiratory Symptoms in Patients With COPD and Type 2 Inflammation: BOREAS and NOTUS.
     Chest. 2025;168:56-66.
     PubMed     Abstract available
     
     
     June 2025
110. KIM H, Choi SH, Ryerson CJ, George PM, et al
     Combined Interstitial Features and Emphysema in National Lung Screening Trial Participants: Prognostic Implications.
     Chest. 2025 Jun 18:S0012-3692(25)00715-9. doi: 10.1016/j.chest.2025.
     PubMed    
     
     
     
111. ALTREE TJ, Pinczel AJ, Toson B, Loffler KA, et al
     The Effects of Low-Dose Morphine on Sleep and Breathlessness in COPD: A Randomized Trial.
     Chest. 2025;167:1578-1590.
     PubMed     Abstract available
     
     
     May 2025
112. SERAJEDDINI H, Thakar A, Kjarsgaard M, Huang C, et al
     Sputum Cellularity and MRI Ventilation Defects in Severe Asthma.
     Chest. 2025 May 20:S0012-3692(25)00648-8. doi: 10.1016/j.chest.2025.
     PubMed     Abstract available
     
     
     
113. YADAV CP, Chakraborty A, Price DB, Mien Lim LH, et al
     Prediction pathway for severe asthma exacerbations: a Bayesian Network analysis.
     Chest. 2025 May 19:S0012-3692(25)00647-6. doi: 10.1016/j.chest.2025.
     PubMed     Abstract available
     
     
     
114. YILMAZ I, Turk M
     Differences in Expert Opinion on Selection of Initial Biologics and Biologic Switching in Severe Asthma.
     Chest. 2025;167:e167.
     PubMed    
     
     
     
115. CELLI BR, Anzueto A, Singh D, Hanania NA, et al
     The Emerging Role of Alarmin-Targeting Biologics in the Treatment of Patients With COPD.
     Chest. 2025;167:1346-1355.
     PubMed     Abstract available
     
     
     
116. FENG Z, Li G, He Q, Sun N, et al
     Associations of Socioeconomic Status and Phenotypic Frailty With Incident COPD: Findings From UK Biobank Participants.
     Chest. 2025;167:1321-1332.
     PubMed     Abstract available
     
     
     April 2025
117. PELAIA G, Jackson DJ, Nair P, Emmanuel B, et al
     XALOC-1: Clinical remission over 2-years with benralizumab in severe eosinophilic asthma.
     Chest. 2025 Apr 19:S0012-3692(25)00441-6. doi: 10.1016/j.chest.2025.
     PubMed     Abstract available
     
     
     
118. AGARWAL R, Muthu V, Sehgal IS
     Evaluation for Allergic Bronchopulmonary Aspergillosis in Patients With Bronchiectasis.
     Chest. 2025;167:e143.
     PubMed    
     
     
     
119. HATANO H, Akamatsu T, Shirai T
     Considerations on Potential Overestimation of Asthma Prevalence.
     Chest. 2025;167:e141.
     PubMed    
     
     
     
120. KHOO YK, Kor AC, Lee CH
     Advancing Lung Ultrasound: Development and Application of the Lung Curtain Swing vs Time Graph in Assessing Asthma Exacerbation.
     Chest. 2025;167:e127-e131.
     PubMed    
     
     
     
121. AARON SD
     Early Diagnosis and Treatment of COPD and Asthma.
     Chest. 2025;167:943-944.
     PubMed    
     
     
     
122. CARTER C, Shah A
     The Fungal Frontier: Understanding the Impact of Aspergillus in Bronchiectasis.
     Chest. 2025;167:914-916.
     PubMed    
     
     
     
123. MERRELL E, Georas SN
     Is Tissue the Issue When It Comes to Severe Asthma?
     Chest. 2025;167:911-913.
     PubMed    
     
     
     
124. HERNANDEZ P, Bosse Y, Bush P, Chapman KR, et al
     Alpha-1-Antitrypsin Deficiency Targeted Testing and Augmentation Therapy: A Canadian Thoracic Society Meta-Analysis and Clinical Practice Guideline.
     Chest. 2025;167:1044-1063.
     PubMed     Abstract available
     
     
     
125. ZHOU P, Yu W, Zhang W, Ma J, et al
     COPD-Associated Expiratory Central Airway Collapse: Current Concepts and New Perspectives.
     Chest. 2025;167:1024-1043.
     PubMed     Abstract available
     
     
     
126. COX NS, McDonald C, Burge AT, Hill CJ, et al
     Comparison of Clinically Meaningful Improvements After Center-Based and Home-Based Telerehabilitation in People With COPD.
     Chest. 2025;167:1003-1011.
     PubMed     Abstract available
     
     
     
127. BROCK JM, Dittrich SA, Eichhorn F, Schlamp K, et al
     Lessons Learned: Risk Factors and Clinical Impact of Severe Pneumothorax After Endoscopic Lung Volume Reduction With Endobronchial Valves.
     Chest. 2025;167:1012-1023.
     PubMed     Abstract available
     
     
     March 2025
128. FREUND O, Bar-Shai A, Alkhazov A, Stav D, et al
     Bronchiectasis in patients with inflammatory bowel diseases - prevalence, predictors, and clinical characteristics.
     Chest. 2025 Mar 28:S0012-3692(25)00405-2. doi: 10.1016/j.chest.2025.
     PubMed     Abstract available
     
     
     
129. HERMANN EA, Yang JX, Angelini E, Balte P, et al
     CT Emphysema Subtypes and Cardiac Hemodynamics Estimated on Magnetic Resonance Imaging: The MESA COPD Study.
     Chest. 2025 Mar 27:S0012-3692(25)00399-X. doi: 10.1016/j.chest.2025.
     PubMed     Abstract available
     
     
     
130. CHOI H, Kwak IY, Oh CR, Goo JM, et al
     Prevalence of Airflow Limitation and Emphysema in Lung Cancer Screening Populations: A Systematic Review and Meta-analysis.
     Chest. 2025 Mar 5:S0012-3692(25)00270-3. doi: 10.1016/j.chest.2025.
     PubMed     Abstract available
     
     
     
131. HENDERSON CJ, Lesnick BL
     Obstructive Lung Disease in Osteogenesis Imperfecta: A Potential Model for Interstitial Lung Disease, COPD, and Asthma.
     Chest. 2025;167:645-646.
     PubMed    
     
     
     
132. EKSTROM M, Lewthwaite H, Li PZ, Bourbeau J, et al
     Identifying Abnormal Exertional Breathlessness in COPD: Comparing Modified Medical Research Council and COPD Assessment Test With Cardiopulmonary Exercise Testing.
     Chest. 2025;167:697-711.
     PubMed     Abstract available
     
     
     
133. SUISSA S, Dell'Aniello S, Ernst P
     Single-Inhaler Triple vs Long-Acting Beta(2)-Agonist-Inhaled Corticosteroid Therapy for COPD: Comparative Safety in Real-World Clinical Practice.
     Chest. 2025;167:712-723.
     PubMed     Abstract available
     
     
     
134. PANKOVITCH S, Frohlich M, AlOthman B, Marciniuk J, et al
     Peak Inspiratory Flow and Inhaler Prescription Strategies in a Specialized COPD Clinical Program: A Real-World Observational Study.
     Chest. 2025;167:736-745.
     PubMed     Abstract available
     
     
     
135. ANDERSEN JD, Lyster ML, Holst MK, Henriksen DP, et al
     Risk of Pulmonary Diseases in Osteogenesis Imperfecta in Denmark: A Register-Based Cohort Study.
     Chest. 2025;167:806-817.
     PubMed     Abstract available
     
     
     February 2025
136. MOZAFFARIPOUR A, Tcherner S, McIntosh MJ, Kooner HK, et al
     Does the Reversal and Normalization of Airway and Pulmonary Vascular Remodeling Accompany Asthma Remission?
     Chest. 2025 Feb 14:S0012-3692(25)00160-6. doi: 10.1016/j.chest.2025.
     PubMed    
     
     
     
137. AMBROSINO P, Vitacca M, Marcuccio G, Spanevello A, et al
     A Comparison of GOLD and STAR Severity Stages in Individuals With COPD Undergoing Pulmonary Rehabilitation.
     Chest. 2025;167:387-401.
     PubMed     Abstract available
     
     
     
138. COLLINS SE, Kirby M, Smith BM, Tan W, et al
     Relationship of Pulmonary Vascular Structure and Function With Exercise Capacity in Health and COPD.
     Chest. 2025;167:402-413.
     PubMed     Abstract available
     
     
     
139. CHOI JY, Lee CH, Joo H, Sim YS, et al
     Implications of Global Lung Function Initiative Spirometry Reference Equations in Northeast Asian Patients With COPD.
     Chest. 2025;167:414-424.
     PubMed     Abstract available
     
     
     
140. CESTELLI L, Johannessen A, Gulsvik A, Stavem K, et al
     Risk Factors, Morbidity, and Mortality in Association With Preserved Ratio Impaired Spirometry and Restrictive Spirometric Pattern: Clinical Relevance of Preserved Ratio Impaired Spirometry and Restrictive Spirometric Pattern.
     Chest. 2025;167:548-560.
     PubMed     Abstract available
     
     
     
141. SCIURBA FC, Christenson SA, Rheault T, Bengtsson T, et al
     Effect of Dual Phosphodiesterase 3 and 4 Inhibitor Ensifentrine on Exacerbation Rate and Risk in Patients With Moderate to Severe COPD.
     Chest. 2025;167:425-435.
     PubMed     Abstract available
     
     
     
142. COSTA FILHO FF, Buckley JD, Furlan A, Campbell S, et al
     Inpatient Complication Rates of Bronchoscopic Lung Volume Reduction in the United States.
     Chest. 2025;167:436-443.
     PubMed     Abstract available
     
     
     January 2025
143. MCCRAVY MS, Ingram JL, Que LG
     Weighing the Options: New Insights and Ongoing Challenges in Asthma With Obesity.
     Chest. 2025;167:1-2.
     PubMed    
     
     
     
144. MARSAA K, Guldin MB, Marques A, Pinnock H, et al
     Understanding Nonpharmacologic Palliative Care for People With Serious COPD: The Individual and Organizational Perspective.
     Chest. 2025;167:112-120.
     PubMed     Abstract available
     
     
     
145. HARVEY-DUNSTAN TC, Baldwin MM, Tal-Singer R, Allinder M, et al
     The Responsiveness of Exercise Tests in COPD: A Randomized Controlled Trial.
     Chest. 2025;167:98-111.
     PubMed     Abstract available
     
     
     
146. ECKHARDT CM, Wu H, Jackson G, Sobel MH, et al
     Extracellular Vesicle-Encapsulated microRNAs and Respiratory Health Among American Indian Participants in the Strong Heart Study.
     Chest. 2025;167:87-97.
     PubMed     Abstract available
     
     
     
147. KIM DH, Jeon ET, Lee HJ, Park H, et al
     Longitudinal Changes in Maximal Forced Inspiratory Flow and Clinical Outcomes in Patients With COPD.
     Chest. 2025;167:76-86.
     PubMed     Abstract available
     
     
     December 2024
148. COSIO BG, Iglesias A, Shafiek H, Mosteiro M, et al
     The role of bronchial biopsy in the prediction of response to biological therapy in severe uncontrolled asthma: a prospective study.
     Chest. 2024 Dec 30:S0012-3692(24)05733-7. doi: 10.1016/j.chest.2024.
     PubMed     Abstract available
     
     
     
149. CHAN R, Gochicoa-Rangel L, Cottini M, Comberiati P, et al
     Ascertainment of small airway dysfunction using oscillometry to better define asthma control and future risk: are we ready to implement it in clinical practice?
     Chest. 2024 Dec 27:S0012-3692(24)05728-3. doi: 10.1016/j.chest.2024.
     PubMed     Abstract available
     
     
     
150. JESENAK M, Bobcakova DA, Djukanovic R, Gaga M, et al
     Promoting Prevention and Targeting Remission of Asthma A EUFOREA Consensus Statement on Raising the Bar in Asthma Care.
     Chest. 2024 Dec 11:S0012-3692(24)05617-4. doi: 10.1016/j.chest.2024.
     PubMed     Abstract available
     
     
     
151. BUSSE WW, Pavord ID, Wechsler ME, Davila IJ, et al
     Stability of Fractional Exhaled Nitric Oxide and its Relationship with Exacerbation in Patients Aged 6 Years or Older with Uncontrolled, Moderate-to-Severe Asthma.
     Chest. 2024 Dec 2:S0012-3692(24)05601-0. doi: 10.1016/j.chest.2024.
     PubMed    
     
     
     
152. JIN Z
     Further Discussion Regarding the Increased Risk of Pertussis in Populations With Asthma or COPD.
     Chest. 2024;166:e201.
     PubMed    
     
     
     
153. BIERBRIER J, Gerstein E, Whitmore GA, Vandemheen KL, et al
     Impact of Dyspnea on Adults With Respiratory Symptoms Without a Defined Diagnosis.
     Chest. 2024;166:1296-1308.
     PubMed     Abstract available
     
     
     
154. OLENGA VUVU LOFUTA P, Klass M, Pauwen N, Kipula AM, et al
     Occupational Exposure to Charcoal Smoke and Dust, a Major Risk Factor for COPD: A Multiregional Cross-Sectional Study in the Democratic Republic of Congo.
     Chest. 2024;166:1334-1346.
     PubMed     Abstract available
     
     
     
155. AKULA M, Nguyen M, Abraham J, Arora VM, et al
     Determining If COPD Self-Management Televisit-Based Interventions Are Evaluated Among and Equitably Effective Across Diverse Patient Populations to Reduce Acute Care Use: A Scoping Review.
     Chest. 2024;166:1371-1393.
     PubMed     Abstract available
     
     
     November 2024
156. MURRAY JK, McNally E, Kent BD
     Clinical accuracy and risk of harm in asthma related content on TikTok.
     Chest. 2024 Nov 9:S0012-3692(24)05466-7. doi: 10.1016/j.chest.2024.
     PubMed    
     
     
     
157. KHALAF Z, Saglani S, Bloom CI
     Implementation and effectiveness of guideline-recommended clinical activities for children with asthma: population-based cohort.
     Chest. 2024 Nov 6:S0012-3692(24)05442-4. doi: 10.1016/j.chest.2024.
     PubMed     Abstract available
     
     
     
158. CHOTIRMALL SH, Chang AB, Chalmers JD
     Infection vs Inflammation: The Bronchiectasis "Tug Of War".
     Chest. 2024;166:928-930.
     PubMed    
     
     
     
159. ZHUO B, Ran S, Qian AM, Zhang J, et al
     Air Pollution Metabolomic Signatures and Chronic Respiratory Diseases Risk: A Longitudinal Study.
     Chest. 2024;166:975-986.
     PubMed     Abstract available
     
     
     
160. MATHIOUDAKIS AG, Bate S, Sivapalan P, Jensen JS, et al
     Rethinking Blood Eosinophils for Assessing Inhaled Corticosteroids Response in COPD: A Post Hoc Analysis From the FLAME Trial.
     Chest. 2024;166:987-997.
     PubMed     Abstract available
     
     
     
161. NIU Y, Niu H, Meng X, Zhu Y, et al
     Associations Between Air Pollution and the Onset of Acute Exacerbations of COPD: A Time-Stratified Case-Crossover Study in China.
     Chest. 2024;166:998-1009.
     PubMed     Abstract available
     
     
     
162. BREMS JH, Vick J, Ashana D, Beach MC, et al
     "Against Medical Advice" Discharges After Respiratory-Related Hospitalizations: Strategies for Respectful Care.
     Chest. 2024;166:1155-1161.
     PubMed     Abstract available
     
     
     
163. METTLER SK, Nath HP, Grumley S, Orejas JL, et al
     Silent Airway Mucus Plugs in COPD and Clinical Implications.
     Chest. 2024;166:1010-1019.
     PubMed     Abstract available
     
     
     October 2024
164. CHOI H, Hughes C, Eke Z, Shuttleworth M, et al
     Clinical Efficacy of Serum Anti-glycopeptidolipid-core IgA Antibody Test for Screening Nontuberculous Mycobacterial Pulmonary Disease in Bronchiectasis: A European Multicenter Cohort Study.
     Chest. 2024 Oct 25:S0012-3692(24)05418-7. doi: 10.1016/j.chest.2024.
     PubMed     Abstract available
     
     
     
165. POLLOCK J, Goeminne PC, Aliberti S, Polverino E, et al
     Aspergillus serology and clinical outcomes in patients with bronchiectasis: data from the European Bronchiectasis Registry (EMBARC).
     Chest. 2024 Oct 24:S0012-3692(24)05400-X. doi: 10.1016/j.chest.2024.06.3843.
     PubMed     Abstract available
     
     
     
166. YANG H, Yang Y, Wang F, Miao C, et al
     Clinical and Prognostic Differences in Mild to Moderate COPD With and Without Emphysema.
     Chest. 2024 Oct 23:S0012-3692(24)05397-2. doi: 10.1016/j.chest.2024.
     PubMed     Abstract available
     
     
     
167. SHARMA V, Ricketts HC, McCombie L, Brosnahan N, et al
     A one-year weight management programme for difficult-to-treat asthma with obesity: a randomised controlled study.
     Chest. 2024 Oct 18:S0012-3692(24)05320-0. doi: 10.1016/j.chest.2024.
     PubMed     Abstract available
     
     
     
168. CHALMERS JD, Burgel PR, Daley CL, DE-Soyza A, et al
     TEMPORARY REMOVAL: A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF BRENSOCATIB IN PATIENTS WITH NON-CYSTIC FIBROSIS BRONCHIECTASIS - THE ASPEN TRIAL.
     Chest. 2024;166.
     PubMed     Abstract available
     
     
     
169. JIN Z
     Does Rheumatoid Arthritis Increase the Risk of COPD?
     Chest. 2024;166:e126-e127.
     PubMed    
     
     
     
170. CARR TF
     The Lifelong Burden of Severe Childhood Asthma.
     Chest. 2024;166:653-654.
     PubMed    
     
     
     
171. ROZENBERG D, Reid WD, Camp P, Campos JL, et al
     Translating the Interplay of Cognition and Physical Performance in COPD and Interstitial Lung Disease: Meeting Report and Literature Review.
     Chest. 2024;166:721-732.
     PubMed     Abstract available
     
     
     
172. QUINTERO SANTOFIMIO V, Knox-Brown B, Potts J, Bartlett-Pestell S, et al
     Small Airways Obstruction and Mortality: Findings From the UK Biobank.
     Chest. 2024;166:712-720.
     PubMed     Abstract available
     
     
     September 2024
173. COUILLARD S, Jackson DJ, Pavord ID, Wechsler ME, et al
     How I do it. Choosing the right biologic for the right patient with severe asthma.
     Chest. 2024 Sep 6:S0012-3692(24)05139-0. doi: 10.1016/j.chest.2024.
     PubMed     Abstract available
     
     
     August 2024
174. SUEN AO, Bischoff K, Iyer AS, Radhakrishnan K, et al
     Differences in Healthcare and Palliative Care Utilization at the End of Life: a Comparison Study Between Lung Cancer, COPD, and IPF.
     Chest. 2024 Aug 24:S0012-3692(24)05049-9. doi: 10.1016/j.chest.2024.
     PubMed     Abstract available
     
     
     
175. TELLO K, Yogeswaran A, Majeed RW, Kiely DG, et al
     Phosphodiesterase-5 Inhibitor Treatment is Associated with Improved Survival in Pulmonary Hypertension Associated with COPD in the PVRI GoDeep Meta-Registry.
     Chest. 2024 Aug 23:S0012-3692(24)05046-3. doi: 10.1016/j.chest.2024.
     PubMed     Abstract available
     
     
     
176. COSTANTINI JG, Lo JC, Ko J, Chandra M, et al
     Ethnic Variation in Asthma Prevalence across Childhood in the Asian American and Pacific Islander Population.
     Chest. 2024 Aug 22:S0012-3692(24)04999-7. doi: 10.1016/j.chest.2024.
     PubMed    
     
     
     
177. WANG JM, Araki T, Cottin V, Han MK, et al
     Quantitative imaging methods in combined pulmonary fibrosis and emphysema.
     Chest. 2024 Aug 16:S0012-3692(24)04921-3. doi: 10.1016/j.chest.2024.
     PubMed     Abstract available
     
     
     
178. RHOADS SL, Mohan A
     A Novel Examination of Azithromycin as a Low-Cost Intervention to Achieve Remission in Asthma.
     Chest. 2024;166:241-242.
     PubMed    
     
     
     
179. BREMS JH, Balasubramanian A, Raju S, Putcha N, et al
     Changes in Spirometry Interpretative Strategies: Implications for Classifying COPD and Predicting Exacerbations.
     Chest. 2024;166:294-303.
     PubMed     Abstract available
     
     
     July 2024
180. YANG HM, Ryu MH, Carey VJ, Young K, et al
     COPD Subtypes Are Differentially Associated with Cardiovascular Events and COPD Exacerbations.
     Chest. 2024 Jul 31:S0012-3692(24)04878-5. doi: 10.1016/j.chest.2024.
     PubMed     Abstract available
     
     
     
181. WALLSTROM O, Stridsman C, Lindberg A, Nyberg F, et al
     Exacerbation history and risk of myocardial infarction and pulmonary embolism in chronic obstructive pulmonary disease.
     Chest. 2024 Jul 31:S0012-3692(24)04880-3. doi: 10.1016/j.chest.2024.
     PubMed     Abstract available
     
     
     
182. PATTI MA, Henderson NB, Phipatanakul W, Jackson-Browne M, et al
     Recommendations for Clinicians to Combat Environmental Disparities in Pediatric Asthma: A Review.
     Chest. 2024 Jul 24:S0012-3692(24)04845-1. doi: 10.1016/j.chest.2024.
     PubMed     Abstract available
     
     
     
183. VAN GANSE E, Louis R
     International Severe Asthma Registry: Closer to the Full Picture of Asthma Care and Outcomes?
     Chest. 2024;166:3-4.
     PubMed    
     
     
     
184. BOURBEAU J, Sin DD
     Global Initiative for Chronic Obstructive Lung Disease and Canadian Thoracic Society COPD Guidelines: Two Sides of the Same Coin or Different Coins?
     Chest. 2024;166:24-27.
     PubMed    
     
     
     
185. SUISSA S
     COUNTERPOINT: Should Triple Inhaled Therapy Be Considered in All Patients With Group E COPD? No.
     Chest. 2024;166:17-20.
     PubMed    
     
     
     
186. ADRISH M, Hanania NA
     POINT: Should Triple Inhaled Therapy Be Considered in All Patients With Group E COPD? Yes.
     Chest. 2024;166:12-17.
     PubMed    
     
     
     
187. EKSTROM M, Li PZ, Lewthwaite H, Bourbeau J, et al
     Abnormal Exertional Breathlessness on Cardiopulmonary Cycle Exercise Testing in Relation to Self-Reported and Physiologic Responses in Chronic Airflow Limitation.
     Chest. 2024;166:81-94.
     PubMed     Abstract available
     
     
     June 2024
188. SAVRAN O, Bonnelykke K, Ulrik CS
     Characteristics of adults with severe asthma in childhood - A 60-year Follow-up Study.
     Chest. 2024 Jun 28:S0012-3692(24)00806-7. doi: 10.1016/j.chest.2024.
     PubMed     Abstract available
     
     
     
189. EWEN R, Pink I, Sutharsan S, Aries SP, et al
     Primary Ciliary Dyskinesia in Adult Bronchiectasis - Data from the German Bronchiectasis Registry PROGNOSIS.
     Chest. 2024 Jun 14:S0012-3692(24)00703-7. doi: 10.1016/j.chest.2024.
     PubMed     Abstract available
     
     
     
190. SATICI C, Bek EO
     The Role of Electronic Nose Analysis of Exhaled Air in Detection of Lung Cancer Among Patients With COPD.
     Chest. 2024;165:e201.
     PubMed    
     
     
     
191. ROSSIDES M
     Rheumatoid Arthritis and COPD: Thinking Beyond Smoking.
     Chest. 2024;165:1278-1279.
     PubMed    
     
     
     
192. MCDERMOTT GC, Sparks JA
     Rheumatoid Arthritis and Bronchiectasis Risk: Additional Evidence Linking Autoimmunity and Airways Disease.
     Chest. 2024;165:1276-1277.
     PubMed    
     
     
     
193. FARMER MJS, Callahan CD, Hughes AM, Riska KL, et al
     Applying Noninvasive Ventilation in Treatment of Acute Exacerbation of COPD Using Evidence-Based Interprofessional Clinical Practice.
     Chest. 2024;165:1469-1480.
     PubMed     Abstract available
     
     
     
194. CHUNG C, Kim H, Han K, Jung J, et al
     Does Rheumatoid Arthritis Increase the Risk of COPD?: A Nationwide Retrospective Cohort Study.
     Chest. 2024;165:1362-1371.
     PubMed     Abstract available
     
     
     
195. KAMINSKA M, Adam V, Orr JE
     Home Noninvasive Ventilation in COPD.
     Chest. 2024;165:1372-1379.
     PubMed     Abstract available
     
     
     May 2024
196. TAN DJ, van Geffen WH, Walters EH
     Impact of Triple Therapy vs Dual Bronchodilator Therapy on Mortality Rates in COPD.
     Chest. 2024;165:e158-e159.
     PubMed    
     
     
     
197. WU WW, Wang G
     How Much Do We Know About Clinical Response and Remission to Add-On Biologics in Severe Asthma in a Real-World Setting.
     Chest. 2024;165:e157-e158.
     PubMed    
     
     
     
198. JOHNSON KM, Duan KI
     The Growing Burden of COPD in the United States.
     Chest. 2024;165:1027-1028.
     PubMed    
     
     
     
199. MANNINO DM, Roberts MH, Mapel DW, Zhang Q, et al
     National and Local Direct Medical Cost Burden of COPD in the United States From 2016 to 2019 and Projections Through 2029.
     Chest. 2024;165:1093-1106.
     PubMed     Abstract available
     
     
     April 2024
200. LEE H, Moon JY, Min KH
     Real-World Clinical Studies to Understand the Current Status and Future Improvements of Pulmonary Rehabilitation in Chronic Lung Diseases.
     Chest. 2024;165:e125.
     PubMed    
     
     
     
201. ASH SY
     Quantitative Imaging and Bronchial Thermoplasty: Technically Impressive But Clinically Uncertain.
     Chest. 2024;165:755-756.
     PubMed    
     
     
     
202. SAMANT M, Krings JG, Lew D, Goss CW, et al
     Use of Quantitative CT Imaging to Identify Bronchial Thermoplasty Responders.
     Chest. 2024;165:775-784.
     PubMed     Abstract available
     
     
     
203. RYU MH, Murphy S, Hinkley M, Carlsten C, et al
     COPD Exposed to Air Pollution: A Path to Understand and Protect a Susceptible Population.
     Chest. 2024;165:836-846.
     PubMed     Abstract available
     
     
     
204. ARON J, Baldomero AK, Rau A, Fiecas MB, et al
     Individual Risk Factors of PM(2.5) Associated With Wintertime Mortality in Urban Patients With COPD.
     Chest. 2024;165:825-835.
     PubMed     Abstract available
     
     
     March 2024
205. GUPTA S, Couillard S, Digby G, Tse SM, et al
     Climate Change and Inhaler Selection in Patients With Respiratory Disease.
     Chest. 2024;165:503-506.
     PubMed    
     
     
     
206. SAHAY S
     Rebuttal From Dr Sahay.
     Chest. 2024;165:498-499.
     PubMed    
     
     
     
207. BINEY IN, Ari A, Barjaktarevic IZ, Carlin B, et al
     Guidance on Mitigating the Risk of Transmitting Respiratory Infections During Nebulization by the COPD Foundation Nebulizer Consortium.
     Chest. 2024;165:653-668.
     PubMed     Abstract available
     
     
     
208. HE D, Yan M, Zhou Y, Ge H, et al
     Preserved Ratio Impaired Spirometry and COPD Accelerate Frailty Progression: Evidence From a Prospective Cohort Study.
     Chest. 2024;165:573-582.
     PubMed     Abstract available
     
     
     February 2024
209. THOMAS D, McDonald VM, Stevens S, Baraket M, et al
     Azithromycin induced asthma remission in adults with persistent uncontrolled asthma: a secondary analysis of a randomised, double-blind, placebo-controlled trial.
     Chest. 2024 Feb 29:S0012-3692(24)00284-8. doi: 10.1016/j.chest.2024.
     PubMed     Abstract available
     
     
     
210. LEE TY, Price D, Yadav CP, Roy R, et al
     International variation in severe exacerbation rates in patients with severe asthma.
     Chest. 2024 Feb 21:S0012-3692(24)00264-2. doi: 10.1016/j.chest.2024.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Obstructive Lung Diseases is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum